Alpha-1 antitrypsin genotypes and associated inhibitory activity towards neutrophil serine proteinases, in vivo

Beata Poplawska-Wisniewska (Warsaw, Poland), Beata Poplawska-Wisniewska, Jadwiga Popow-Stellmaszyk, Radoslaw Struniawski, Aneta Stepniewska, Emil Wojda, Magdalena Wysocka, Pawel Sliwinski, Malgorzata Czajkowska-Malinowska, Beata Wajda, Dorota Krawiecka, Ewa Jassem, Sabina Janciauskiene, Adam Lesner, Joanna Chorostowska-Wynimko

Source: International Congress 2015 – Translational research in respiratory care: new findings
Session: Translational research in respiratory care: new findings
Session type: Thematic Poster Session
Number: 867
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Beata Poplawska-Wisniewska (Warsaw, Poland), Beata Poplawska-Wisniewska, Jadwiga Popow-Stellmaszyk, Radoslaw Struniawski, Aneta Stepniewska, Emil Wojda, Magdalena Wysocka, Pawel Sliwinski, Malgorzata Czajkowska-Malinowska, Beata Wajda, Dorota Krawiecka, Ewa Jassem, Sabina Janciauskiene, Adam Lesner, Joanna Chorostowska-Wynimko. Alpha-1 antitrypsin genotypes and associated inhibitory activity towards neutrophil serine proteinases, in vivo. Eur Respir J 2015; 46: Suppl. 59, 867

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Alpha-1 antitrypsin genotypes and associated inhibitory activity towards neutrophil serine proteinases, in vitro
Source: International Congress 2015 – Promising novel findings in translational pulmonary research
Year: 2015

Macrophage phenotype does not affect protease anti-protease imbalance in COPD
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015

SerpinB1 in cystic fibrosis airway fluids: quantity, molecular form and mechanism of elastase inhibition
Source: Eur Respir J 2011; 37: 1083-1090
Year: 2011



Dipeptidyl peptidase I (DPPI) cleaves surfactant protein D (SP-D): A mechanism for immune compromise in the lung
Source: International Congress 2016 – Molecular immunology of the lung
Year: 2016



Neutrophil elastase gene expression and relation with lung function in Alpha-1 Antitrypsin deficiency patients.
Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases
Year: 2017

LSC Abstract – A functional variant of secretory leukocyte protease inhibitor (SLPI) with improved anti-inflammatory activity against pulmonary infection
Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects
Year: 2015

Development of secretory leukocyte protease inhibitor (SLPI) variants resistant to degradation by neutrophil elastase
Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases
Year: 2014

LATE-BREAKING ABSTRACT: alpha-1 antitrypsin activates protein phosphatase 2A (PP2A) to counter lung inflammatory responses
Source: International Congress 2014 – Lung cell biology in injury and repair
Year: 2014

Alpha-1 antitrypsin protects protein phospholipid transfer protein from cleavage to counter lung inflammatory responses
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015

Plant proteinase inhibitor from crataeva tapia (CrataBl) attenuates inflammation and remodelling induced by elastase in mice
Source: Annual Congress 2013 –Novel mechanisms in lung injury
Year: 2013

MiR-320c regulates SERPINA1 expression and is associated with pulmonary disease in alpha-1-antitrypsin deficiency
Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Year: 2016

Genes affecting mRNA stability and metalloproteinase inhibitor RECK are down-regulated in patients with COPD
Source: Annual Congress 2013 –New insights into epigenetic mechanisms in the lung
Year: 2013



A functional variant of secretory leukocyte protease inhibitor (SLPI) with improved anti-inflammatory activity against pulmonary infection
Source: Lung Science Conference 2015
Year: 2015

Similar adaptive immune response in COPD patients with and without alpha1 antitrypsin deficiency
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013

Identification of novel pathogenic mechanisms triggered by arginase activation in patients with COPD
Source: International Congress 2016 – Airway response to infection
Year: 2016


-82 A>G promoter polymorphism in the gene of human macrophage elastase (MMP-12) as a risk factor for COPD and bronchial asthma
Source: International Congress 2014 – Basic and translational research in asthma and COPD
Year: 2014


Lysosomal cysteine proteases in the lung: role in protein processing and immunoregulation
Source: Eur Respir J 2004; 23: 620-628
Year: 2004



Increased proportion of slow decliners in patients with alpha-1 protease inhibitor (A1-PI) deficiency following treatment with A1-PI
Source: International Congress 2016 – New and old therapies for chronic lung diseases
Year: 2016


Assessment of A1-PI dose-exposure and exposure-response relationships in patients with Alpha-1 antitrypsin inhibitor deficiency
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015


MMP2 -1306C>T polymorphism and the enzyme plasma levels in patients with COPD
Source: International Congress 2015 – Translational research in respiratory care: new findings
Year: 2015